Lite Strategy

LITSNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$29.997 M

$0.97 -10.19%

Close of 6 Nov 2026

As of 6 Nov 2026, Lite Strategy (LITS) has a market capitalization of $30.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$0.00

#3616 by revenue

Earnings

-$15.9M

Loss-making

Shares outstanding

30,407,268

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#361ProMIS NeurosciencesPMN$31.7M
#362Rockwell MedicalRMTI$30.8M
#363Lite StrategyLITS$30.0M
#364Edesa BiotechEDSA$28.9M
#365BriaCell TherapeuticsBCTX$28.7M

Insiders buying

All insider buying →

One open-market purchase by officers and directors of Lite Strategy, worth $12.6K. Grants and option exercises are excluded.

Nicholas Glover$12.6K
2,000 shares at $6.28 on 22 Jul 2025 · filed 26 Oct 2026

What if Lite Strategy were worth as much as…

Open the what-if tool →

Gold $28.2T

$913,083.84

Per share 941,324× higher

Bitcoin $1.53T

$49,405.38

Per share 50,933× higher

Apple $5.02T

$162,193.24

Per share 167,210× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Lite Strategy are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.